tirzepatide plotter GLP-1 plotter: the complete guide to tracking your medication levels Tirzepatide Unlikely to Exacerbate DR

Description

Researchers analyzed health records from over 290,000 people and found no significant association between semaglutide use and the risk of nonarteritic anterior ischemic optic neuropathy (NAION), a serious cause of sudden vision loss

Missing HbA1c and weight values were imputed from mixed models for repeated measures

(WROC) Excellus BlueCross BlueShield is pushing back against reports that it will no longer cover GLP-1 medications, saying drugs used to treat certain medical conditions remain cove...

Semaglutide, which falls under a class of medications knowns as GLP-1s, saw significant decreases when compared with insulin and other GLP-1s.

The typical maintenance doses for GLP-1 receptor agonists are: liraglutide 1.8 mg daily, semaglutide 1.0 mg weekly (injectable) or 14 mg daily (oral), and du...